Literature DB >> 21331502

Inflammation and transplantation tolerance.

Daniel R Goldstein1.   

Abstract

Although our understanding of the immunological mechanisms of transplant tolerance induction has greatly improved, how the innate immune system impacts transplant tolerance has only been recently appreciated. In this review, the involvement of the innate immune receptors, Toll-like receptors (TLRs), in both experimental models of acute allograft rejection and transplant tolerance induction in addition to clinical studies of organ transplantation are described. Several inflammatory cytokines, including IL-6, TNF-α, and type I interferons, which are induced by TLRs and other activators of innate immunity, prevent transplant tolerance induction. Their induction may be provoked by environmental exposures, such as viral or bacterial infections. Further investigation as to the innate inflammatory basis that controls the balance between immune acceptance and allograft rejection may lead us closer to the elusive goal of transplant tolerance acquisition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21331502     DOI: 10.1007/s00281-011-0251-2

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  56 in total

Review 1.  Tregs and transplantation tolerance.

Authors:  Patrick T Walsh; Devon K Taylor; Laurence A Turka
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.

Authors:  Thomas B Thornley; Michael A Brehm; Thomas G Markees; Leonard D Shultz; John P Mordes; Raymond M Welsh; Aldo A Rossini; Dale L Greiner
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

3.  The role of hyaluronan degradation products as innate alloimmune agonists.

Authors:  B M Tesar; D Jiang; J Liang; S M Palmer; P W Noble; D R Goldstein
Journal:  Am J Transplant       Date:  2006-11       Impact factor: 8.086

Review 4.  Nod-like proteins in immunity, inflammation and disease.

Authors:  Jörg H Fritz; Richard L Ferrero; Dana J Philpott; Stephen E Girardin
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

5.  The identity of innate immune activators in organ transplantation: origins from within or exterior to the host?

Authors:  D R Goldstein
Journal:  Am J Transplant       Date:  2007-05-25       Impact factor: 8.086

Review 6.  Toll-like receptor and RIG-I-like receptor signaling.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

7.  Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

Authors:  S T Smiley; J A King; W W Hancock
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

8.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

9.  CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice.

Authors:  Bryna E Burrell; Keri Csencsits; Guanyi Lu; Svetlana Grabauskiene; D Keith Bishop
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 10.  Tracking the toll of kidney disease.

Authors:  Anushree C Shirali; Daniel R Goldstein
Journal:  J Am Soc Nephrol       Date:  2008-06-25       Impact factor: 10.121

View more
  11 in total

1.  Antigenic challenge in the etiology of autoimmune disease in women.

Authors:  Mary A M Rogers; Deborah A Levine; Neil Blumberg; Gwenith G Fisher; Mohammed Kabeto; Kenneth M Langa
Journal:  J Autoimmun       Date:  2011-08-30       Impact factor: 7.094

2.  α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection.

Authors:  Galit Shahaf; Hadas Moser; Eyal Ozeri; Mark Mizrahi; Avishag Abecassis; Eli C Lewis
Journal:  Mol Med       Date:  2011-06-09       Impact factor: 6.354

3.  B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy.

Authors:  Takayuki Yamamoto; Qi Li; Hidetaka Hara; Liaoran Wang; Hongmin Zhou; Juan Li; Devin E Eckhoff; A Joseph Tector; Edwin C Klein; Ray Lovingood; Mohamed Ezzelarab; David Ayares; Yi Wang; David K C Cooper; Hayato Iwase
Journal:  Transpl Immunol       Date:  2018-08-06       Impact factor: 1.708

Review 4.  Impact of infection on transplantation tolerance.

Authors:  Shuangjin Yu; Chang Su; Xunrong Luo
Journal:  Immunol Rev       Date:  2019-09-19       Impact factor: 12.988

5.  Anti-complement component C5 mAb synergizes with CTLA4Ig to inhibit alloreactive T cells and prolong cardiac allograft survival in mice.

Authors:  H Raedler; M B Vieyra; S Leisman; P Lakhani; W Kwan; M Yang; K Johnson; S J Faas; P Tamburini; P S Heeger
Journal:  Am J Transplant       Date:  2011-06-10       Impact factor: 8.086

6.  Therapeutic regulation of systemic inflammation in xenograft recipients.

Authors:  Hayato Iwase; Hong Liu; Tao Li; Zhongquiang Zhang; Bingsi Gao; Hidetaka Hara; Martin Wijkstrom; Cassandra Long; Ryan Saari; David Ayares; David K C Cooper; Mohamed B Ezzelarab
Journal:  Xenotransplantation       Date:  2017-03-12       Impact factor: 3.907

7.  Systemic inflammation in xenograft recipients precedes activation of coagulation.

Authors:  Mohamed B Ezzelarab; Burcin Ekser; Agnes Azimzadeh; Chih Che Lin; Yuming Zhao; Rachael Rodriguez; Gabriel J Echeverri; Hayato Iwase; Cassandra Long; Hidetaka Hara; David Ayares; Richard N Pierson; Angus W Thomson; David K Cooper
Journal:  Xenotransplantation       Date:  2014-09-11       Impact factor: 3.907

8.  Erythropoietin stimulation of human adipose tissue for therapeutic refilling releases protective cytokines.

Authors:  Maurizio Sabbatini; Michela Bosetti; Alessia Borrone; Liah Moalem; Antonio Taveggia; Giovanni Verna; Mario Cannas
Journal:  J Tissue Eng       Date:  2016-09-27       Impact factor: 7.813

Review 9.  Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms.

Authors:  Lloyd D'Orsogna; Heleen van den Heuvel; Cees van Kooten; Sebastiaan Heidt; Frans H J Claas
Journal:  Immunogenetics       Date:  2017-07-17       Impact factor: 2.846

10.  Innate immunity and resistance to tolerogenesis in allotransplantation.

Authors:  Gilles Benichou; Makoto Tonsho; Georges Tocco; Ognjenka Nadazdin; Joren C Madsen
Journal:  Front Immunol       Date:  2012-04-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.